Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1751
DELISTED
Potbelly
PBPB
| $4.21M | ﹤0.01% |
1,846,695
+19,600
| +1% | +$53.7K |
2014 Q4
22 quarters
|
|
1752
Vanguard Short-Term Bond ETF
BSV
$45.4B
| $4.2M | ﹤0.01% |
50,502
-64,298
| -56% | -$5.32M |
2019 Q4
2 quarters
|
|
1753
Host Hotels & Resorts
HST
$15.7B
| $4.2M | ﹤0.01% |
388,865
-511,179
| -57% | -$5.87M |
2019 Q1
5 quarters
|
|
1754
Conagra Brands
CAG
$6.61B
| $4.18M | ﹤0.01% |
118,981
+63,181
| +113% | +$2.11M |
2020 Q1
1 quarter
|
|
1755
First Bancorp
FNLC
$378M
| $4.18M | ﹤0.01% |
192,595
-25,005
| -11% | -$515K |
2013 Q2
28 quarters
|
|
1756
Donaldson
DCI
$10.1B
| $4.17M | ﹤0.01% |
+89,600
| New | +$3.96M |
2020 Q2
0 quarters
|
|
1757
Orrstown Financial Services
ORRF
$808M
| $4.17M | ﹤0.01% |
282,399
-1,477
| -0.5% | -$19.7K |
2013 Q2
28 quarters
|
|
1758
Banco Macro
BMA
$4.08B
| $4.13M | ﹤0.01% |
222,497
+128,797
| +137% | +$2.38M |
2019 Q2
4 quarters
|
|
1759
DELISTED
Enstar Group
ESGR
| $4.13M | ﹤0.01% |
27,000
-10,100
| -27% | -$1.49M |
2018 Q4
6 quarters
|
|
|
CFMS
1760
DELISTED
Conformis, Inc. Common Stock
CFMS
| $4.12M | ﹤0.01% |
201,168
-9,442
| -4% | -$197K |
2017 Q3
11 quarters
|
|
|
AKCA
1761
DELISTED
Akcea Therapeutics Inc
AKCA
| $4.12M | ﹤0.01% |
300,504
+266,104
| +774% | +$4.11M |
2019 Q4
2 quarters
|
|
1762
Hovnanian Enterprises
HOV
$570M
| $4.12M | ﹤0.01% |
175,915
-35,700
| -17% | -$540K |
2016 Q4
14 quarters
|
|
1763
Comscore
SCOR
$58M
| $4.11M | ﹤0.01% |
66,362
-2,500
| -4% | -$150K |
2019 Q2
4 quarters
|
|
|
ECOL
1764
DELISTED
US Ecology, Inc.
ECOL
| $4.11M | ﹤0.01% |
121,306
-78,900
| -39% | -$2.57M |
2020 Q1
1 quarter
|
|
1765
DELISTED
Farmer Brothers
FARM
| $4.1M | ﹤0.01% |
558,500
+26,100
| +5% | +$210K |
2013 Q2
28 quarters
|
|
1766
Power REIT
PW
$2.57M
| $4.1M | ﹤0.01% |
14,250
+3,130
| +28% | +$616K |
2013 Q2
28 quarters
|
|
1767
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$2.87B
| $4.09M | ﹤0.01% |
79,200
+74,000
| +1,423% | +$3.77M |
2018 Q4
6 quarters
|
|
1768
SmartFinancial
SMBK
$851M
| $4.09M | ﹤0.01% |
252,574
-30,200
| -11% | -$441K |
2017 Q1
13 quarters
|
|
1769
Belden
BDC
$4.07B
| $4.08M | ﹤0.01% |
125,500
+52,607
| +72% | +$1.75M |
2018 Q4
6 quarters
|
|
|
PTLA
1770
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.08M | ﹤0.01% |
226,500
-712,497
| -76% | -$9.91M |
2019 Q4
2 quarters
|
|
1771
DELISTED
Penns Woods Bancorp
PWOD
| $4.07M | ﹤0.01% |
179,102
-2,400
| -1% | -$53.6K |
2013 Q2
28 quarters
|
|
1772
Prothena Corp
PRTA
$430M
| $4.06M | ﹤0.01% |
387,962
+303,062
| +357% | +$3.37M |
2019 Q3
3 quarters
|
|
1773
RH
RH
$2.1B
| $4.06M | ﹤0.01% |
16,300
-1,258,879
| -99% | -$228M |
2019 Q2
4 quarters
|
|
1774
DELISTED
VOXX International Corporation Class A
VOXX
| $4.06M | ﹤0.01% |
701,720
+138,398
| +25% | +$688K |
2015 Q4
18 quarters
|
|
1775
ARK Innovation ETF
ARKK
$8.79B
| $4.05M | ﹤0.01% |
56,800
+47,100
| +486% | +$2.76M |
2019 Q4
2 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 583 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.